3rd webinar in the Oncofactory series
ERBC Group invites you to the third webinar in a series on September 2023.
"Clinical case study on the predictability of the avian embryo model (AVI-PDX™) with guest speakers from the clinics"
On September 28, from 11:30am to 12:15pm CEST / 5:30am to 6:15am EDT (date and time to be confirmed), the third webinar in the series will be held to introduce ERBC's innovative technology platform based on the generation of patient tumor replicas in avian embryos (avian embryo patient-derived xenograft: AVI-PDX). This platform was developed and patented by Oncofactory, which was acquired by ERBC Group in December 2022.
During this webinar, you will delve deeper into the clinical applications of the model and further explore the published scientific data related to it. The presentation will focus on a compelling case study derived from a publication in EMBO Molecular Medicine. This case study will illustrate the use of the model in human melanoma research, with a particular focus on how the avian in vivo platform can predict patient response to targeted therapies.
The webinar will be led by three distinguished experts: Stéphane Dalle, PU-PH, Head of the Department of Oncodermatology, Lyon Sud Hospital, Valérie Castellani-Lincontang, PhD, Founder and Chief Scientific Officer of Oncofactory and Céline Delloye-Bourgeois, PhD, Founder and Associate Scientific Director of Oncofactory
👉 REGISTER NOW BY CLICKING ON THE FOLLOWING LINK
The time of this Sept 28 session does not work for your schedule. Register anyway and get access to the session replay!.